IndraLab

Statements


| 15

reach
"Myeloid-lineage-specific deletion of USP18 suppresses tumor progression."

reach
"Furthermore, we transfected USP18 overexpression plasmids into bladder cancer cell lines stably overexpressing BCCE4[A] and found that USP18 overexpression restored the tumor‐suppressing function of BCCE4[A] (Figure S26, Supporting Information)."

reach
"PLX3397 abrogated USP18 deficiency-induced reduction in pro-tumor/immunosuppressive macrophages (Figure 4C), supporting that USP18-mediated downregulation of CSF1R expression contributes to macrophage polarization.In addition to the changes in TAM population, there were significant changes in T cell population."

reach
"USP18 enhanced tumor growth in vivo via mediating POU4F1 and PRKAA2."

reach
"41 , 42 Consistent with the above findings, we also found that USP18 could restore the tumor‐suppressing function of BCCE4[A], indicating that USP18 plays an oncogenic role in bladder cancer."

reach
"Here, we show that deletion of USP18 in myeloid cells suppresses tumor progression."

reach
"In the tumor, this signaling drives expression of angiogenic and immunosuppressive myeloid chemokines CXCL1, CXCL10, and CCL5; protumor interferon-stimulated genes ISG15 and IFIT3; and oncoprotein USP18, all of which promote tumor growth and metastases, and are selectively blocked by nciLT but not by ciLT."

reach
"USP18 could promote tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1 [13]."

reach
"It has been reported that USP18, an important protein involved in chemotherapy resistance, can induce autophagy, and inhibition of USP18 can effectively inhibit tumor resistance to the chemotherapy dr[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Here, we report that deletion of USP18 in myeloid cells suppresses tumor growth and enhances activation of cytotoxic CD8 cells."

reach
"USP18 expression in B16 melanoma tumor cells modulates immune cell phenotypes, including increasing MHC class-I expression, impairing tumor cell-mediated inhibition of T cell proliferation and activat[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"In malignant tumors, USP18 is elevated and activates AKT/mTOR signaling, promotes phosphorylated AKT (p-AKT) and p-mTOR protein expression, leading to cancer cell proliferation and migration (106)."

reach
"Silencing USP18 reduced tumor growth in vivo by mediating POU4F1/PRKAA2 axis."

reach
"In males, androgens modulate the expression of USP18 via binding and activation of the androgen receptor (AR) transcription factor, thereby promoting tumor initiation and progression [14]."

reach
"Compared with normal saline treatment, paclitaxol treatment significantly inhibited tumor growth, and USP18 knockdown slightly reduced tumor growth ( Fig. 4 A&B)."